Gilead Sciences to Present at Upcoming Investor Conferences

Audio By Carbonatix

FOSTER CITY, Calif.--(BUSINESS WIRE)--Feb 23, 2026--

Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its executives will be speaking at the following investor conferences:

• TD Cowen Annual Health Care Conference on Tuesday, March 3 at 11:10 AM Eastern Time

• Leerink Partners Global Healthcare Conference on Tuesday, March 10 at 11:20 AM Eastern Time

• Barclays Annual Global Healthcare Conference on Wednesday, March 11 at 11:00 AM Eastern Time

The live webcasts can be accessed at the company’s investors page at investors.gilead.com. The replays will be available for at least 30 days following the presentation.

About Gilead Sciences

Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis, COVID-19, and cancer. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California.

For more information on Gilead Sciences, please visit the company’s website at www.gilead.com, follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.

View source version on businesswire.com:https://www.businesswire.com/news/home/20260223506818/en/

CONTACT: Jacquie Ross, CFA – Investors

[email protected]

KEYWORD: MASSACHUSETTS CALIFORNIA FLORIDA UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: BIOTECHNOLOGY HOSPITALS PHARMACEUTICAL HEALTH

SOURCE: Gilead Sciences, Inc.

Copyright Business Wire 2026.

PUB: 02/23/2026 04:05 PM/DISC: 02/23/2026 04:05 PM

http://www.businesswire.com/news/home/20260223506818/en